12/04/2013 | Sebastian Waldstein
Predicting treatment outcomes manages their expectations and improves your care.
12/02/2013 | Mark Hillen
If you had VMT or MH and could avoid vitrectomy, you would. Might ocriplasmin let you?
Bayer and Regeneron have presented the phase III trial data for aflibercept treatment of myopic choroidal neovascularization
10/29/2013 | Florian Gekeler
Can transcorneal electrical stimulation help reverse retinal degeneration in retinitis pigmentosa? Ongoing clinical trials suggest that it may.
10/29/2013 | Scott Mackie
Screening macular pigment density aids early detection of age-related macular degeneration. Here’s a guide to a snappy one-minute test using autofluorescence spectrometry.
10/29/2013 | David Keegan
Why I offer implantable miniature telescopes (IMTs) to my patients with bilateral end-stage macular degeneration.
10/29/2013 | Fedra Hajizadeh
Enhanced depth imaging optical coherence tomography has allowed high-quality imaging of the choroid for the first time, with wide implications for patient outcome.
10/28/2013 | Gregory Hageman
Striking variation in its presentation, progression, genetics and biology suggest that AMD may be a collection of closely-related conditions.
10/28/2013 | Sophia Ktori
In an animal model of ischemic retinal disease, a single Ang1 injection suppresses vascular leakage and stimulates blood vessel formation
09/23/2013 | Eberhart Zrenner
Retinal implants offer hope for the treatment of inherited blindness. Clinical trials of battery-powered subretinal and epiretinal devices have demonstrated that patients with retinitis pigmentosa, blind for many years, can once again recognize objects.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: